Table 3 Survival analysis after diagnosis of NLNM in patients with EOC
From: Clinical features and outcomes of neck lymphatic metastasis in ovarian epithelial carcinoma
| Â | Univariate Analysis | Â | Multivariate Analysis | Â |
|---|---|---|---|---|
Variables | Hazard Ratio | P | Hazard Ratio | P |
(95% CI) | (95% CI) | |||
Age | 1.00 (0.95 – 1.05) | 0.89 | 1.06 (0.99 – 1.13) | 0.09 |
NLNM | ||||
At initial surgery (Group A) | 1 | Â | 1 | Â |
At cancer recurrence (Group B) | 3.91 (1.25 – 12.23) | 0.02 | 4.52 (1.07 – 19.18) | 0.04 |
Histology | ||||
Serous | 1 | Â | 1 | Â |
Non-serous | 6.90 (1.83 – 26.09) | 0.004 | 18.67 (1.97 – 176.90) | 0.01 |
Bone or lung metastasis | 2.21 (0.69 – 7.01) | 0.18 | 0.28 (0.05 – 1.59) | 0.15 |
Brain metastasis | 7.76 (2.02 – 29.86) | 0.003 | 6.93 (1.42 – 33.75) | 0.02 |